CVS Group plc Exercise of SAYE Options and PDMR Dealing (5840Z)

TIDMCVSG

RNS Number : 5840Z

CVS Group plc

12 January 2024

12 January 2024

CVS Group Plc

("CVS" or the "Company")

Exercise of SAYE Options and PDMR Dealing

CVS, one of the UK's leading providers of integrated veterinary services, announces that on 10 January 2024, options over a total of 41,174 ordinary shares of 0.2 pence each (the "Ordinary Shares") were exercised under the CVS Group 2020 SAYE Plan (2020/2024), at an exercise price of GBP10.09.

The issuance of shares in connection with the SAYE Exercise was fully satisfied by 41,174 Ordinary Shares held by the CVS Group Employee Benefit Trust (the "EBT"). Following the SAYE Exercise, a total of 6,771 Ordinary Shares are held by the EBT, representing approximately 0.009% of the Company's total voting rights.

Richard Fairman, Chief Executive Officer exercised options over 606 Ordinary Shares in the Company. The balance of the options were exercised by certain other employees and former employees of the Company.

Following his option exercise, Richard Fairman, along with any persons closely associated, holds a beneficial interest in 78,107 Ordinary Shares in the Company, representing approximately 0.109% of the total voting rights of the Company, calculated on the same basis.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker) [phone]

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

Berenberg (Joint Broker) [phone]

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

Camarco (Financial PR)

Geoffrey Pelham-Lane [phone]

Ginny Pulbrook [phone]

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                             Richard Fairman 
     -------------------------------  ---------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                  Chief Executive Officer 
     -------------------------------  ---------------------------------- 
 b)   Initial notification             Initial Notification 
       /Amendment 
     -------------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                             CVS Group plc 
     -------------------------------  ---------------------------------- 
 b)   LEI                              213800J41XDQ2NX48O05 
     -------------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 
 
 a)   Description of the financial   Ordinary shares of 0.2 pence each 
       instrument, type of 
       instrument                     GB00B2863827 
 
       Identification code 
 b)   Nature of the transaction     Exercise of options under the 2020 
                                     SAYE Plan (1 January 2024 maturity) 
     -----------------------------  ------------------------------------ 
 c)   Price(s) and volume(s)         Price(s)    Volume 
                                       GBP10.09     606 
     -----------------------------  ------------------------------------ 
 d)   Aggregated information 
 
        *    Aggregated volume 
                                       N/A - single transaction 
 
 
        *    Price 
     -----------------------------  ------------------------------------ 
 e)   Date of the transaction        10 January 2024 
     -----------------------------  ------------------------------------ 
f)    Place of the transaction       London Stock Exchange - AIM 
     -----------------------------  ------------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHXLLFFZFLEBBZ

(END) Dow Jones Newswires

January 12, 2024 08:56 ET (13:56 GMT)